Trial Profile
A phase I trial of gemcitabine followed by flavopiridol [alvocidib] in patients with solid tumors
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 02 Mar 2013
Price :
$35
*
At a glance
- Drugs Alvocidib (Primary) ; Gemcitabine (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 11 Sep 2005 New trial record.